ZFY2 inhibitors belong to a class of compounds that specifically target the zinc finger protein Y-linked 2 (ZFY2), a transcription factor found primarily on the Y chromosome in mammals. ZFY2 is involved in various molecular and genetic processes, particularly related to the regulation of gene expression. Structurally, zinc finger proteins, including ZFY2, contain zinc ion-binding domains that stabilize their folded configuration, allowing them to interact with DNA sequences in a highly specific manner. ZFY2 inhibitors act by disrupting this interaction, typically through interfering with the zinc finger domains or binding to other regions of the protein, thereby modulating its function. The inhibition of ZFY2 can impact the transcriptional regulation of certain genes, leading to downstream effects on cellular processes, especially those linked to sex chromosome-linked pathways and spermatogenesis.
From a chemical perspective, ZFY2 inhibitors can vary in their molecular design, depending on the mechanism of inhibition. Some inhibitors are small molecules designed to chelate zinc ions, destabilizing the zinc finger domain and thus preventing proper DNA binding. Others may be designed to mimic DNA substrates or bind to allosteric sites on the protein, disrupting protein conformation. Understanding the binding kinetics, specificity, and structural interactions of these inhibitors is crucial for delineating how they interfere with ZFY2 function. Advanced structural biology techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy are commonly employed to study the interaction between ZFY2 and its inhibitors, providing insights into the precise molecular mechanisms at play. Additionally, the selectivity of ZFY2 inhibitors toward specific zinc finger proteins is an important factor, as off-target effects could lead to unintended impacts on other zinc finger proteins with structural similarities.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor that can alter gene expression, potentially affecting ZFY2. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, potentially affecting the methylation status of genes regulated by ZFY2. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Another histone deacetylase inhibitor, altering chromatin structure and gene expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
A DNA methyltransferase inhibitor, potentially modifying expression of genes regulated by ZFY2. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
A BET bromodomain inhibitor, possibly influencing transcription factors including ZFY2. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
A selective histone deacetylase inhibitor, affecting gene regulation and expression. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
A histone deacetylase inhibitor, could impact the expression of genes regulated by ZFY2. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
A DNA methyltransferase inhibitor, could affect the methylation status of genes regulated by ZFY2. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
A potent histone deacetylase inhibitor, affecting gene expression broadly, including ZFY2-regulated genes. | ||||||
CPI-203 | 1446144-04-2 | sc-501599 | 1 mg | $170.00 | ||
A BET bromodomain inhibitor, which may impact the regulation of ZFY2 and associated genes. |